cordblood banking

Saturday, September 04, 2010

Archive for January, 2009

Maia’s Cord Blood Miracle – Part 2 of 2

rnrnPart 2 of 2 A re-infusion of stem cells taken from umbilical cord blood changed the life of 4-year-old Maia Friedlander, who was developmentally delayed from birth. She received a second chance thanks to a groundbreaking procedure pioneered by Dr Joanna Kurtzberg, a leading pediatric oncologist at Duke University in North Carolina, USA. nnMaias parents first heard about cord blood being used to fix brain injury when Mary Schneider, who was the first person to have the treatment for her son Ryan’s cerebral palsy, visited New Zealand in April this year. Three years on, Mary says Ryan is clear of all issues, needs no more therapies, and is totally well, a typical five-year-old boy. The Friedlanders were determined to get Maia into the Duke programme and emailed and phoned nearly daily for the next four months. They felt they had nothing to lose and owed it to Maia to see whether this could change her life too. Their persistence paid off. nnIn late August, Maia and her mum Jillian flew to Duke to have the stem cells her parents stored with CordBank New Zealand put back into her blood stream via an intravenous drip. Once in her system, its a matter of waiting for her cord blood stem cells to find their way to the damaged tissue in her brain and begin rebuilding it. Jillian didnt have to wait long. Only two days after Maias re-infusion, her balance seemed to have improved. Her eyes became more focused and alert, she could run with confidence and she even started speaking; things she simply hadnt done before.nnhttp://www.cordbank.co.nz/cord-blood-banking/

Technorati Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Cord Blood Collection – Some Basic Information

cord blood
Inadequate knowledge about cord blood collection, processing and cord blood storage is pushing many new parents away from donating their babies cord blood cells. Hence, comprehensive information on steps of collection, processing and storage of cord blood cells is required to educate them and help them release their fear of unknown risks, if any, involved in the methods. Cord blood collection methods, whether post or pre delivery don’t expose the child or the mother to any risk and pain. With all the miraculous therapeutic benefits of cord blood cells, a once disposable umbilical cord is now worthy of being stored to retrieve the diverse life saving opportunities from it.

Types Of Blood Cord Collection Methods

Cord blood storage follows two prior steps:

Collection

Processing

First and foremost is the blood cell collection. There are two methods. Both are considered equally safe. Collection methods vary according to the period of collection

Ex utero method implies involves placing the placenta in a sterile supporting structure, where the clamped and cut off umbilical cord is injected with a syringe to drain the blood cells in a bag.

In utero (or before the placenta is delivered) method refers to the collection that takes place when the doctor or the midwife is waiting for placenta to be delivered or the period of 5 to 10 minutes before the delivery of placenta. In utero method involves the same procedure, except its time of collection.

Both women undergoing vaginal and cesarean deliveries can consider donating umbilical cord blood stem cells, as the methods are safe for both types of deliveries. However, if during the final stages of pregnancy, complications arise, the cord blood bank and the physicians may select to abandon the plan for cord blood collection. Along with collecting cord blood cells from umbilical vein, mothers blood gets also collected to detect some infectious diseases as per regulations. Around 40 to 150ml stem cells are drained from the umbilical cords to collect adequate cells for transplantation. The specialists try to collect as cord blood as possible. Incase the blood collected isn’t sufficient, the blood is still preserved for possible stem cell expansion or if the parents agree, for scientific research. After collection, the blood cells are then forwarded to the cord blood bank facility chosen by the parents. Blood bank centers then test and examine blood to detect presence of infectious diseases or typecasting the tissues.

Processing Of Cord Blood Cells

After cord blood banking, samples are transferred to the labs within 36 to 48 hours of collection. Different thoughts have suggested various ways of processing cord cells. Laboratories that are CLIA certified, at the same time, have registered with FDA test moms blood for diseases like syphilis, hepatitis, HLTV, HIV, Malaria and CMV. The processing part, along with ensuring infectious disease status, ensures that blood cells are eligible to be used for transplanting on family members besides autologous use. A point to note here’s that the mother usually has to undergo a special test during cord blood registry to ensure that she is eligible for the cord blood donation. The results are sent to the parents so that they can prepare themselves for treatment if required.

Preservation Of Cord Blood Cells

During processing, cord blood cells are depleted of red blood cells, while some processing methods keep the red blood cells. After processing of cells, comes the next procedure of cord blood preservation. When the unit containing cord blood cells is processed, a cyropreservant is added to it. This is added to make the unit survive the cryogenic process. As the unit drops its temperature to -90 degree Celsius, a liquid nitrogen tank is used for cord blood storage. The units of cord blood are preserved in special bags divided into two compartments. One is for immediate use (if required) and the other is for stem cell expansion.

The childs parents or guardians are given the rights to unit for their transplanting use in future. Later, at the onset of legal age, the child possesses control over his or her cord blood cells. For those worried about privacy issues, the cord blood banks assure the donors for complete secrecy. At no stage will the donors identity be revealed to the recipient, especially if the latter is a stranger.

By: Apurva Shree

About the Author:

n

Cord blood storage in a cord blood bank can save your family from many dreaded diseases. The umbilical cord blood is rich in stem cells, which is used in the treatment of killer diseases. If you decide not to store your babys cord blood in a private cord blood bank, then you can donate it to a public cord blood bank at no cost. Visit Cord Blood Banking for an understanding of types of cord blood banks and their processes.
rn

n

Related Blogs

Technorati Tags: , , , , , , , , , , , , , , , , , , ,

Parents credit cord blood transplant with healing daughter’s brain

The cheery toddler runs down the hall, waving her arms above her head as she reaches her target.
Chloe Levine, 2 1/2 , jumps into the arms of her dad, Ryan Levine, and the two share a snuggle.
“Running like that with two arms up in the air was impossible before,” says Chloe’s mom, Jenny Levine, 32.
Chloe, who has cerebral palsy, was transplanted with her own stem cells on May 27, 2008, as part of a study at Duke University.
The cells were collected at birth from Chloe’s umbilical cord and frozen, months before her parents knew there was anything wrong with their precious daughter. They were stored in Tucson at Cord Blood Registry, near Tucson International Airport.
Scientists debate whether stem cells can help children such as Chloe, or if the improvement in motor skills would have occurred anyway.
But the Levines believe Chloe’s improvement since the transplant is nothing short of a miracle.
“She’s normal now,” says Jenny Levine, as her daughter colors a picture of Elmo with a bright pink crayon. “She’s doing everything a normal 2-year-old does.”
When Chloe’s parents were expecting her sister, Shayla, now 5, they investigated the possibility of storing her cord blood. But they could not afford the initial $2,000 investment at the time.
When pregnant with Chloe, Jenny Levine was determined to store her second child’s cord blood.
“It was one of the first things we decided,” she said. “There have always been two things in life that scare me the most, cancer and car accidents. We looked at it as a life insurance policy.”
The family was living in Pinetop when Chloe was born. They now live in Denver, where Jenny stays home with the girls and Ryan, 34, is in the cell phone business.
Jenny had a difficult pregnancy, and Chloe was born a month early.
“But every indication was that she was just fine,” she said.
At 9 months, the couple worried that Chloe could not hold her bottle. “Her little right hand was always in a tight fist,” Jenny recalled.
They took her to a pediatrician, who didn’t seem concerned.
“But my instincts told me something was not right,” Jenny said.
At her year check-up, Jenny told the pediatrician she was not crawling, and didn’t put weight on her right side. A brain scan showed Chloe had hemiplegic cerebral palsy, and that she suffered a stroke in utero, probably early in pregnancy. Some of Chloe’s brain tissue, Jenny said, stopped developing.
The family consulted a Phoenix neurologist. “I told him we had cord blood stored, and asked if there was any possible use,” Jenny recalled. “He said, “No, it won’t benefit you.’ ”
They were told Chloe would need physical, occupational and speech therapy throughout her childhood. ”We trusted what he had to say, accepted what we had to do and we went home,” Jenny said.
In December 2007, the family heard about Dallas Hextell, a Sacramento boy with cerebral palsy who had been infused with his own stem cells as part of the study at Duke, and was responding well.
“I immediately got in contact with Duke,” Jenny said. The hope, she said, is that the infusion of stem cells could cause brain tissue to regenerate, improving Chloe’s mobility.
“They will not guarantee you anything,” Jenny said, “The worst that can happen is nothing happens.”
“We didn’t have any expectations, but we wanted to know we had tried everything,” Ryan said.
Last May, Chloe’s stored stem cells were tested and sent to Duke, where she was infused through an IV in her arm. Her parents say they saw a nearly immediate change.
“She woke up the next day and she was a different kid,” Jenny said. “Two days later, in the car, she said her first word, ‘Coco,’ her nickname.”
At her grandparents’ house a couple of days after infusion, Chloe was able to use her right foot to push the pedal of a toy tractor, something she had not been able to do before.
The family will return to Duke in May or June for evaluation. Dr. Joanne Kurtzberg, the Duke transplant specialist who treated Chloe, is not granting media interviews, and the study is still in it’s early stages.
But the Levines believe the transplant is saving their daughter.
“It has been life-changing in every aspect,” Jenny said. “She no longer needs speech therapy, and we are seeing improvement every day. It’s amazing.”
AAP cord blood recommendations
When deciding whether to bank your baby’s cord blood, discuss the options with your obstetrician. Here is what to consider when deciding which company to select, according to the American Academy of Pediatrics:
Does the company bank for personal and family use?
Institutional Review Board-approved protocols should be in place, including annual disclosure of the financial interest and potential conflicts of interest.
Financial viability and stability of the company should be considered.
Physician should disclose any potential conflict of interest.
Company should have an informed consent process in place and require the parent to sign an informed consent.
Cord blood banks should comply with national accreditation standards developed by the Foundation for the Accreditation of Cellular Therapy, the U.S. Food and Drug Administration, the Federal Trade Commission and similar state agencies.

Technorati Tags: , , , , , , , , , , , , , , , , , , ,

Saving child’s cord blood: medicine or marketing?

Last spring, Chloe Levine dragged her tiny right foot as she struggled to walk.
The toddler’s right hand remained clenched in a fist. She did not speak, and her eyes were glazed over.
Cerebral palsy caused by a stroke in utero prevented Chloe from developing like other children.
But after an experimental infusion of her own stem cells – collected from her umbilical cord at birth, frozen and stored in Tucson – Chloe, 2 1/2, is running, kicking a soccer ball and coloring.
“It’s my prayer that some day we can erase the diagnosis,” said Chloe’s mom, Jenny Levine, a former Pinetop resident who lives in Denver. “Even if that doesn’t happen, she’s come a heck of a long way.”
Chloe, who is part of a trial at Duke University, is one of 33 patients who last year were infused with their own stem cells that had been taken from their umbilical cords and stored in Tucson at Cord Blood Registry. It is the largest private cord blood bank, storing a quarter of a million units from around the world.
The number of transplants of a person’s own stem cells through CBR tripled in 2008, as more transplants are conducted in trials in regenerative medicine. Scientists are studying whether an infusion of a person’s own cells collected at birth can repair damaged tissues.
“We really look at what we do as providing hope for longer, healthier lives,” said Tom Moore, CBR’s founder and CEO.
“When we are talking about regenerative medicine, we are talking about cures.”
Parents spend $2,000 initially for cells to be collected and stored, and about $125 a year for maintenance.
Use of the cells is not politically controversial, as in the case of embryonic stem cells.
But marketing strategies of businesses that store the cells are. The American Academy of Pediatrics, which many concerned parents turn to regarding the health of their child, recommends privately banking cells only if an ill older sibling might benefit.
Storing cord blood as “biological insurance” should be discouraged because there is no scientific data to support that transplanting a person’s stem cells works, it says.
“Private cord blood banks target parents at an emotionally vulnerable time when the reality is most conditions that might be helped by cord blood stem cells already exist in the infant’s cord blood,” according to the academy’s Web site.
The academy strongly recommends donating cord blood to a public bank. Donations, which cannot later be retrieved by the family, can help others battling illness.
No public bank exists in Arizona. But Tucsonans can donate through Cryobanks International in Altamonte Springs, Fla. (See box.)
Additionally, some in the scientific community question whether patients like Chloe were likely to improve without the transplant.
Cord Blood Registry officials call the academy’s statement “outdated” at a time when the science of cord blood stem cells is changing and expanding rapidly.
They also say they are educating parents, not encouraging them to bank based on fear.
Cord blood stem cells are being used experimentally to treat brain injuries like Chloe’s, Type 1 diabetes, heart disease and other illnesses. CBR officials say the cells potentially hold the cure for more than 70 diseases.
Moore and his staff say they believe one day a person’s stem cells might be used to cure everything from hearing loss to knee injuries.
“I think some day, kids will talk about stem cell transplants like getting a flu shot,” said Dondi Pulse-Earle, who coordinates transplants at CBR. “It will be, ‘Hey, have you used your stem cells yet?’ ”
Nationally, there are about 30 private banks. CBR started in 1992 after Moore said he discovered the best research was conducted by University of Arizona immunologist David Harris.
Harris, who is also CBR’s scientific director, has been researching stem cells since 1989 and started the bank here with his son’s cord blood.
The bank is now housed in a 60,000-square-foot state-of-the-art facility near the Tucson International Airport. Tucson was also selected because of few instances of natural disasters that could shut down the airport or the bank.
Harris agrees public banking is needed. One operated in Tucson for a decade, until funding ran out, he said.
The state was expected to start public banking again this year after the Arizona Legislature approved $5 million over five years to fund the project, Harris said.
But the bank was a victim of the budget crisis and funding was cut, he said. He predicts it will be years before a public bank will be funded.
Public banks are especially needed for minority patients and those of mixed race, who are less likely to have stored cells privately, he said.
Harris said the American Academy of Pediatrics has put parents in a tough spot by only recommending public banking.
“If you’re going to tell me to donate, you need to make sure I can donate,” he said of the limited public banks available.
While 22 states are approved for public banking, only six collect donated cord blood stem cells from births at specific hospitals, Harris said.
But Dr. William T. Shearer, the professor of pediatrics and immunology at Baylor College of Medicine who helped write the academy’s position on private storing, said families can donate to public banks, but they must be proactive, finding a bank in a different state.
Shearer said the academy’s position is not outdated.
He called claims of being able to fix future disease and injury using a person’s own cells “a little far fetched, frankly.”
But he said the uses of donated cells are immediate and greatly needed.
Private banks argue that transplants with a person’s cells are more effective and safer. But Shearer said effectiveness has not been proved.
“This goes beyond medicine and into marketing,” he said.
But Harris argues the use of one’s own stem cells has tremendous potential to cure.
At UA, he has conducted research into how stem cells affect cerebral palsy and other traumatic brain injuries, as well as Type 1 diabetes.
Harris found that cord blood stem cell transplants cured mice of diabetes over the span of their life, about two years.
A study of 23 children with Type 1 diabetes at the University of Florida has shown improvements when they are infused with their own stem cells. Some children are making their own insulin, Harris said.
What is not known is whether the disease will reoccur, he said.
While much about regenerative medicine is unknown, Harris said changes in patients make it impossible to dismiss.
“When you see enough patients benefiting, you say, ‘Something’s going on here.’ ”
Harris agreed there are probably private companies that market to parents’ fears, but he says CBR is not one of them.
His advice to expectant parents: “Make an informed decision early on. You only have one opportunity. Make a decision and don’t look back. You don’t want to do this out of fear. You want to consider it if you think it could be a viable resource that you can call upon should you need it.”
Tucson parents Heather and Gary George had no doubts when it came to storing their children’s cord blood.
They have stored stem cells of children Isabelle, 2 1/2, and Jasper, 16 months, and plan to store the cells of their third child, due Jan. 27.
“I’m a nurse, and I know about stem cells and the fantastic opportunities available in the future for therapies,” said Heather George, 32. “Knowing what I know, I could not have chosen not to save the cord blood.”
They chose to store at CBR because of the few major weather disasters that could shut down the facility. They also like that the blood does not have to travel across the country.
She knows it is unlikely her children will ever need the cells.
“But heaven forbid something happen, how awful that would be if we had not saved them,” she said.
For some parents, the peace of mind they get saving cells is worth the investment, said Dr. David Beyda, a medical ethicist, critical care doctor at Phoenix Children’s Hospital and a UA clinical professor of pediatrics.
Beyda is not familiar with CBR, but he spoke in general of ethical concerns regarding private cord blood banking.
“What’s it worth to you as a parent? Is it peace of mind? If it is, then do it,” Beyda said. “If you think it’s a guarantee (of a cure for any future illness), then be cautious.”
Ethical concerns are raised, he said, when companies play on the fears of expectant parents through advertising.
Marketing techniques that use the potential for guilt are unethical, Beyda said.
“What happens if your child at age 5 gets leukemia? Do you want your child to die?” is the marketing strategy used by some companies, he said.
Beyda said the number of transplants nationally is very small, and viability as a long-term fix is unknown.
“When you look at scientific information, it’s extremely sparse in terms of evidence that it’s beneficial,” he said.
The American College of Obstetricians and Gynecologists released guidelines last year, recommending that health-care professionals provide balanced information on private and public banking. But its Web site says chances are “remote” that cells from a baby’s banked cord blood will be used to treat that child or another family member.
CBR, however, says there is “solid scientific evidence” from animal studies that transplants can induce healing and that the uses are likely to expand.
In addition to the 33 stem cell transplants through CBR last year where patients received their own cells, another seven transplants were used to treat siblings, according to CBR.
Moore, of CBR, said the possible uses are far reaching.
“If you can provide a positive outcome in that child and make them whole again, you can have a significant impact,” he said.

Technorati Tags: , , , , , , , , , , , , , , , , , , ,

$19 million state stem cell funding enlisted John Hopkins and University of Maryland into the …

The Maryland Stem Cell Research Commission has granted awards for 59 projects, out of 147 applications that it received.

The grants have been highly desired by leading scientists since federal funding on new stem cell research was banned in 2001. Maryland launched the stem cell commission in 2006 and is one of a handful of states that started funding stem cell research after the federal ban.

The largest grants are given to scientists who have preliminary data supporting their research are entitled to receive the largest grants. That awards are range from $55,000 to $300,000 per year.

The stem cell grant will aimed at the the following research subjects:

  • Generation of patient-specific iPS cells for modeling and treating Gaucher disease.
  • A novel stem cell therapy for spinal cord injury-induced chronic neuropathic pain
  • Understanding functions of schizophrenia susceptibility genes using pluripotent human stem cells.
  • Scale-Up Manufacturing, Authentication, and Banking of Human Pluripotent Stem Cells.
  • The role of transglutaminase in adhesion-dependent and growth factor-mediated responses of mesenchymal stem cells.

To see the entire list of stem cell research to be done by scientists from Hopkins and University of Maryland click here.

Filed under Americas, New study, Spinal Cord Injury, Stem Cell, induced pluripotent stem cell | Comment Below

Technorati Tags: , , , , , , , , , , , , , , , , , , ,

SEO Powered by Platinum SEO from Techblissonline